Clinical trial of Inofer has started
Uppsala 2018-10-05The clinical study for the iron tablets Inofer, which Drugsson AB (subsidiary of Double Bond Pharmaceutical) has the rights for in Sweden, Norway, Denmark and Finland has now begun. A clinical trial of Inofer was approved, as previously reported, by the Swedish Medical Products Agency and the Ethical Vetting Board on June 20th and yesterday, 4thof September, the first patient received treatment with Inofer tablets. The study is conducted at Skellefteå lasarett and is headed by chief physician Kurt Boman, senior professor at Umeå University. "We hope the study will